Numab
Anne Kerschenmeyer is a Research Associate at Numab Therapeutics AG since October 2021, with prior experience as a Staff Research Associate at Philochem AG from October 2018 to September 2021, and as a Research Technician at UniversitätsSpital Zürich's Institute of Neuropathology from June 2016 to September 2018. Anne's early career included a role as a Research Assistant at ETH Zürich from September 2015 to May 2016. A Master of Science in Biochemistry and Molecular Biology was obtained from ETH Zürich in 2015, following a Bachelor of Science in Biology from the same institution in 2013. Research focused on the anti-oxidant and anti-inflammatory properties of sulfated alginates in osteoarthritis, resulting in a publication in Biomaterial Science in 2017.
This person is not in any offices
Numab
Numab Therapeutics is an oncology-focused biopharmaceutical company based in the Zurich-area, Switzerland. At Numab, they are writing the next chapter in cancer immunotherapy by creating multi-specific antibodies that enable the pursuit of novel therapeutic strategies.